Cargando…

Optimizing frontline therapy in advanced urothelial cancer

Detalles Bibliográficos
Autores principales:	Kwon, Whi-An, Seo, Ho Kyung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354316/ https://www.ncbi.nlm.nih.gov/pubmed/32676379 http://dx.doi.org/10.21037/tau.2020.04.03

Ejemplares similares

Novel G9a/DNMT first-in-class dual reversible inhibitor has potent antitumor effect in bladder cancer
por: Kwon, Whi-An, et al.
Publicado: (2020)

Emerging agents for the treatment of metastatic urothelial cancer
por: Kwon, Whi-An, et al.
Publicado: (2021)

Usefulness of the mass screening program for colorectal cancer in China: further long-term validation is needed to confirm its value
por: Kwon, Whi-An, et al.
Publicado: (2020)

Caplacizumab as frontline therapy in addition to standard treatment in iTTP
por: Cid, Joan, et al.
Publicado: (2022)

From the frontlines to centre stage: resilience of frontline health workers in the context of COVID-19
por: Nanda, Priya, et al.
Publicado: (2020)

Surgery at the frontline at the time of the COVID‐19 outbreak
por: Testori, Alberto, et al.
Publicado: (2020)

The impact of excess body weight at the hospital frontline
por: Renehan, Andrew G, et al.
Publicado: (2014)

Flavonoids on the Frontline against Cancer Metastasis
por: Eltahir, Sarah, et al.
Publicado: (2023)

Tumor-Associated Mast Cells in Urothelial Bladder Cancer: Optimizing Immuno-Oncology
por: Choi, Hae Woong, et al.
Publicado: (2021)

Clinical implications and practical considerations for poly-ADP-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder
por: Lee, Hye Won, et al.
Publicado: (2022)

Optimizing adjuvant therapy in EGFR-mutated non-small cell lung cancer
por: Shepherd, Annemarie F., et al.
Publicado: (2020)

Caution in the age of optimism; a salient lesson in advanced melanoma
por: Roberts, Hayley N., et al.
Publicado: (2020)

COVID-19: mobilising CT as a frontline management tool
por: Syed, Imran, et al.
Publicado: (2020)

Achieving Positive Mental Health and Wellbeing on the COVID-19 Frontline
por: Hoay Khoo, Vicky Poh, et al.
Publicado: (2020)

Resilience for Frontline Health Care Workers: Evidence-Based Recommendations
por: Southwick, Steven M., et al.
Publicado: (2021)

Accelerating Early Access to Immunotherapies for Advanced Urothelial Carcinoma
por: Ning, Yang‐Min, et al.
Publicado: (2017)

Clinical Pharmacists: An Invaluable Part of the Coronavirus Disease 2019 Frontline Response
por: Ferguson, Nadia C., et al.
Publicado: (2020)

Frontline Health-Care Workers in Combating the COVID-19: Respect and Reflect
por: Li, Yuan, et al.
Publicado: (2020)

Prioritizing vulnerable populations and women on the frontlines: COVID-19 in humanitarian contexts
por: Sharma, Vandana, et al.
Publicado: (2020)

More on the use of frontline caplacizumab in immune-mediated thrombotic thrombocytopenic purpura
por: Picod, Adrien, et al.
Publicado: (2022)

A Frontline Driver at Crossroads
por: Cho, Hune
Publicado: (2011)

Resilience—Need of the Hour for the “Frontliners”
por: Samavedam, Srinivas
Publicado: (2022)

In search of goldilocks: the quest to optimize combination drug strategies for the management of advanced stage non-small-cell lung cancer
por: Bindal, Poorva, et al.
Publicado: (2020)

Frontline therapy for advanced hepatocellular carcinoma: an update
por: Akce, Mehmet, et al.
Publicado: (2022)

First-line immune checkpoint inhibitors for patients with metastatic urothelial carcinoma treated in routine clinical practice
por: Naito, Renato, et al.
Publicado: (2020)

Conversion therapy for advanced cholangiocarcinoma in the era of molecular targeted therapy and immune therapy
por: Zhang, Zunyi, et al.
Publicado: (2023)

Does perioperative systemic therapy represent the optimal therapeutic paradigm in organ-confined, muscle-invasive urothelial carcinoma?
por: Scafuri, Luca, et al.
Publicado: (2021)

Is pembrolizumab monotherapy the optimal treatment for elderly patients with PD-L1 positive advanced non-small cell lung cancer?
por: Mienko, Fiona, et al.
Publicado: (2020)

Enhancing the Psychological Well-Being of Frontline Essential Service Providers of COVID-19
por: Vinayak, Seema
Publicado: (2020)

Veverimer: an advance in base therapy for metabolic acidosis
por: Brady, Clayton, et al.
Publicado: (2020)

Animal Model of Interstitial Cystitis/Bladder Pain Syndrome
por: Kwon, Whi-An
Publicado: (2018)

Contact tracing: digital health on the frontline
por: The Lancet Digital Health
Publicado: (2020)

Suggestions from Cremona, Italy: 2 months into the pandemic at the frontline of COVID-19 in Europe
por: Pan, A., et al.
Publicado: (2020)

Trimodality therapy in variant urothelial carcinoma: choose wisely
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2017)

Understanding the biology of urothelial cancer metastasis
por: Kobayashi, Takashi
Publicado: (2016)

Sequence of therapies for advanced BRAFV600E/K melanoma
por: Gonzalez-Cao, Maria, et al.
Publicado: (2023)

Diabetes and CoViD-19: Experience from the frontline of Internal Medicine wards in Italy
por: Montagnani, A., et al.
Publicado: (2020)

Taking the bull by the horn: the frontline use of infliximab for the treatment of immune checkpoint inhibitor-induced enterocolitis
por: Esfahani, Khashayar
Publicado: (2018)

Urothelial Carcinoma
por: Chow, Nan-Haw, et al.
Publicado: (2012)

Recent advances in medical therapy for metastatic urothelial cancer
por: Yuasa, Takeshi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qi99iasclvi9mtt900mkes7jn0